Literature DB >> 31237493

Imaging Diagnosis and Follow-up of Advanced Prostate Cancer: Clinical Perspectives and State of the Art.

Raquel Perez-Lopez1, Nina Tunariu1, Anwar R Padhani1, Wim J G Oyen1, Stefano Fanti1, Hebert Alberto Vargas1, Aurelius Omlin1, Michael J Morris1, Johann de Bono1, Dow-Mu Koh1.   

Abstract

The management of advanced prostate cancer has changed substantially with the availability of multiple effective novel treatments, which has led to improved disease survival. In the era of personalized cancer treatments, more precise imaging may help physicians deliver better care. More accurate local staging and earlier detection of metastatic disease, accurate identification of oligometastatic disease, and optimal assessment of treatment response are areas where modern imaging is rapidly evolving and expanding. Next-generation imaging modalities, including whole-body MRI and molecular imaging with combined PET and CT and combined PET and MRI using novel radiopharmaceuticals, create new opportunities for imaging to support and refine management pathways in patients with advanced prostate cancer. This article demonstrates the potential and challenges of applying next-generation imaging to deliver the clinical promise of treatment breakthroughs. © RSNA, 2019.

Entities:  

Mesh:

Year:  2019        PMID: 31237493     DOI: 10.1148/radiol.2019181931

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

1.  Diagnostic value of retrospectively fused 64CuCl2 PET/MRI in biochemical relapse of prostate cancer: comparison with fused 18F-Choline PET/MRI, 64CuCl2 PET/CT, 18F-Choline PET/CT, and mpMRI.

Authors:  Francesco Paparo; Alice Peirano; João Matos; Lorenzo Bacigalupo; Umberto Rossi; Ilaria Mussetto; Gianluca Bottoni; Martina Ugolini; Carlo Introini; Filippo Grillo Ruggieri; Gian Andrea Rollandi; Arnoldo Piccardo
Journal:  Abdom Radiol (NY)       Date:  2020-11

2.  Radiation therapy with curative intention in men with de novo metastatic prostate carcinoma: shoot'em all!

Authors:  Angel Montero; Ovidio Hernando; Veronica Cañon; Diana Guevara; Jeannete Valero; Xin Chen-Zhao; Paz Garcia-Acilu; Emilio Sanchez; Mercedes Lopez; Raquel Ciervide; Mariola Garcia-Aranda; Beatriz Alvarez; Alejandro Prado; Rosa Alonso; Pedro Fernandez-Leton; Carmen Rubio
Journal:  Rep Pract Oncol Radiother       Date:  2021-08-12

Review 3.  Whole body imaging in musculoskeletal oncology: when, why, and how.

Authors:  Joao R T Vicentini; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2022-07-09       Impact factor: 2.199

4.  Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression.

Authors:  Kathleen Ruchalski; Hyun J Kim; Michael Douek; Steven Raman; Maitraya Patel; Victor Sai; Antonio Gutierrez; Benjamin Levine; Cheryce Fischer; Martin Allen-Auerbach; Pawan Gupta; Heidi Coy; Bianca Villegas; Matthew Brown; Jonathan Goldin
Journal:  Cancer Imaging       Date:  2022-07-14       Impact factor: 5.605

5.  Evaluation of the Efficiency of MRI-Based Radiomics Classifiers in the Diagnosis of Prostate Lesions.

Authors:  Linghao Li; Lili Gu; Bin Kang; Jiaojiao Yang; Ying Wu; Hao Liu; Shasha Lai; Xueting Wu; Jian Jiang
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

6.  Imaging response assessment for oncology: An algorithmic approach.

Authors:  Kathleen Ruchalski; Rohit Dewan; Victor Sai; Lacey J McIntosh; Marta Braschi-Amirfarzan
Journal:  Eur J Radiol Open       Date:  2022-06-07

Review 7.  The role of MRI in prostate cancer: current and future directions.

Authors:  Maria Clara Fernandes; Onur Yildirim; Sungmin Woo; Hebert Alberto Vargas; Hedvig Hricak
Journal:  MAGMA       Date:  2022-03-16       Impact factor: 2.533

Review 8.  The Role of Radical Prostatectomy and Lymph Node Dissection in Clinically Node Positive Patients.

Authors:  Giovanni Motterle; Mohamed E Ahmed; Jack R Andrews; R Jeffrey Karnes
Journal:  Front Oncol       Date:  2019-12-10       Impact factor: 6.244

Review 9.  Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer.

Authors:  Giulia Marvaso; Stefania Volpe; Matteo Pepa; Mattia Zaffaroni; Giulia Corrao; Matteo Augugliaro; Franco Nolè; Ottavio De Cobelli; Barbara Alicja Jereczek-Fossa
Journal:  Cancer Manag Res       Date:  2022-01-06       Impact factor: 3.989

Review 10.  The role of artificial intelligence in medical imaging research.

Authors:  Xiaoli Tang
Journal:  BJR Open       Date:  2019-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.